Condition
Ganglioneuroma
Total Trials
6
Recruiting
3
Active
5
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
Early P 1 (1)
P 1 (1)
Trial Status
Recruiting3
Active Not Recruiting2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT02402244Recruiting
Project: Every Child for Younger Patients With Cancer
NCT04040088Early Phase 1Active Not Recruiting
An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors
NCT05192980Not ApplicableRecruiting
SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours
NCT03583528Active Not Recruiting
DOTATOC PET/CT for Imaging NET Patients
NCT06296732Recruiting
Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification
NCT01999270Phase 1Completed
Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors
Showing all 6 trials